Single-cell landscape revealed immune characteristics associated with disease phases in brucellosis patients

Abstract

A comprehensive immune landscape for Brucella infection is crucial for developing new treatments for brucellosis. Here, we utilized single-cell RNA sequencing (scRNA-seq) of 290,369 cells from 35 individuals, including 29 brucellosis patients from acute (n = 10), sub-acute (n = 9), and chronic (n = 10) phases as well as six healthy donors. Enzyme-linked immunosorbent assays were applied for validation within this cohort. Brucella infection caused a significant change in the composition of peripheral immune cells and inflammation was a key feature of brucellosis. Acute patients are characterized by potential cytokine storms resulting from systemic upregulation of S100A8/A9, primarily due to classical monocytes. Cytokine storm may be mediated by activating S100A8/A9-TLR4-MyD88 signaling pathway. Moreover, monocytic myeloid-derived suppressor cells were the probable contributors to immune paralysis in acute patients. Chronic patients are characterized by a dysregulated Th1 response, marked by reduced expression of IFN-γ and Th1 signatures as well as a high exhausted state. Additionally, Brucella infection can suppress apoptosis in myeloid cells (e.g., mDCs, classical monocytes), inhibit antigen presentation in professional antigen-presenting cells (APCs; e.g., mDC) and nonprofessional APCs (e.g., monocytes), and induce exhaustion in CD8⁺ T/NK cells, potentially resulting in the establishment of chronic infection. Overall, our study systemically deciphered the coordinated immune responses of Brucella at different phases of the infection, which facilitated a full understanding of the immunopathogenesis of brucellosis and may aid the development of new effective therapeutic strategies, especially for those with chronic infection.

Keywords

Brucella infection / brucellosis / cytokine storm / immune response / single-cell sequencing

References

[1] Lai, Shengjie, Qiulan Chen, and Zhongjie Li. 2021. “Human Brucellosis: An Ongoing Global Health Challenge.” China CDC Weekly 3: 120-123. https://doi.org/10.46234/ccdcw2021.031

[2] Hull, Noah C., and Brant A. Schumaker. 2018. “Comparisons of Brucellosis between Human and Veterinary Medicine.” Infection Ecology & Epidemiology 8: 1500846. https://doi.org/10.1080/20008686.2018.1500846

[3] Liu, Zhiguo, Liping Gao, Miao Wang, Min Yuan, and Zhenjun Li. 2024. “Long Ignored but Making a Comeback: A Worldwide Epidemiological Evolution of Human Brucellosis.” Emerging Microbes & Infections 13: 2290839. https://doi.org/10.1080/22221751.2023.2290839

[4] Głowacka, Patrycja, Dorota Żakowska, Katarzyna Naylor, Marcin Niemcewicz, and Agata Bielawska-Drózd. 2018. “Brucella−Virulence Factors, Pathogenesis and Treatment.” Polish Journal of Microbiology 67: 151-161. https://doi.org/10.21307/pjm-2018-029

[5] de Figueiredo, Paul, Thomas A. Ficht, Allison Rice-Ficht, Carlos A. Rossetti, and Garry L. Adams. 2015. “Pathogenesis and Immunobiology of Brucellosis.” The American Journal of Pathology 185: 1505-1517. https://doi.org/10.1016/j.ajpath.2015.03.003

[6] Martirosyan, Anna, and Jean Pierre Gorvel. 2013. “Brucella Eevasion of Adaptive Immunity.” Future Microbiology 8: 147-154. https://doi.org/10.2217/fmb.12.140

[7] Dean, Anna S., Lisa Crump, Helena Greter, Jan Hattendorf, Esther Schelling, and Jakob Zinsstag. 2012. “Clinical Manifestations of Human Brucellosis: A Systematic Review and Meta-Analysis.” PLoS Neglected Tropical Diseases 6: e1929. https://doi.org/10.1371/journal.pntd.0001929

[8] Amjadi, Omolbanin, Alireza Rafiei, Masoud Mardani, Parisa Zafari, and Ahmadreza Zarifian. 2019. “A Review of the Immunopathogenesis of Brucellosis.” Infectious Diseases 51: 321-333. https://doi.org/10.1080/23744235.2019.1568545

[9] Jiang, Hai, Lan Feng, and Jinxing Lu. 2020. “Updated Guidelines for the Diagnosis of Human Brucellosis−China, 2019.” China CDC Weekly 2: 487-489. https://doi.org/10.46234/ccdcw2020.129

[10] Doganay, Mehmet, and Bilgehan Aygen. 2003. “Human Brucellosis: An Overview.” International Journal of Infectious Diseases 7: 173-182. https://doi.org/10.1016/S1201-9712(03)90049-X

[11] Liu, Zhiguo, Miao Wang, Yaxin Tian, Zhongqiu Li, Liping Gao, and Zhenjun Li. 2022. “A Systematic Analysis of and Recommendations for Public Health Events Involving Brucellosis from 2006 to 2019 in China.” Annals of Medicine 54: 1859-1866. https://doi.org/10.1080/07853890.2022.2092894

[12] Xu, Limin, Jing Zhang, Yiqian He, Qianqian Yang, Tianhao Mu, Qiushi Guo, Yingqiang Li, Tian Tong, Shifu Chen, and Richard D. Ye. 2023. “ScRNAPip: A Systematic and Dynamic Pipeline for Single-Cell RNA Sequencing Analysis.” iMeta 2: e132. https://doi.org/10.1002/imt2.132

[13] Wang, Yi, Laurence Don Wai Luu, Shuang Liu, Xiong Zhu, Siyuan Huang, Fang Li, Xiaolan Huang, et al. 2023. “Single-Cell Transcriptomic Analysis Reveals a Systemic Immune Dysregulation in COVID-19-associated Pediatric Encephalopathy.” Signal Transduction and Targeted Therapy 8: 398. https://doi.org/10.1038/s41392-023-01641-y

[14] Wang, Yi, Qing Sun, Yun Zhang, Xuelian Li, Qingtao Liang, Ru Guo, Liqun Zhang, et al. 2023. “Systemic Immune Dysregulation in Severe Tuberculosis Patients Revealed by a Single-Cell Transcriptome Atlas.” Journal of Infection 86: 421-438. https://doi.org/10.1016/j.jinf.2023.03.020

[15] Akbulut, H. Handan, Sirri S. Kilic, Vedat Bulut, and Mehmet Ozden. 2005. “Determination of Intracellular Cytokines Produced by Th1 and Th2 Cells Using Flow Cytometry in Patients With Brucellosis.” FEMS Immunology and Medical Microbiology 45: 253-258. https://doi.org/10.1016/j.femsim.2005.04.001

[16] Wang, Yang, Yuxiang Li, Haijun Li, Hongxiao Song, Naicui Zhai, Lixin Lou, Feng Wang, et al. 2017. “Brucella Dysregulates Monocytes and Inhibits Macrophage Polarization through LC3-Dependent Autophagy.” Frontiers in Immunology 8: 691. https://doi.org/10.3389/fimmu.2017.00691

[17] Rahmanpour, Mina, Fariba Keramat, Sanaz Jourghasemi, Golnaz Rashidi, Mohsen Abdolmaleki, Ghasem Solgi, and Mehrdad Hajilooi. 2019. “Direct Correlation between Th1 and Th17 Responses in Immunity to Brucella Infection.” Microbes and Infection 21: 441-448. https://doi.org/10.1016/j.micinf.2019.05.002

[18] Ghaznavi Rad, Ehsanollah, Khadijeh Khosravi, Nader Zarinfar, and Ghasem Mosayebi. 2017. “Reduced IFN-γ Production in Chronic Brucellosis Patients.” Iranian Journal of Immunology 14: 215-222.

[19] Baldi C., Pablo, and Guillermo H. Giambartolomei. 2013. “Immunopathology of Brucella Infection.” Recent Patents on Anti-infective Drug Discovery 8: 18-26. https://doi.org/10.2174/1574891x11308010005

[20] Wang, Siwen, Rui Song, Ziyi Wang, Zhaocheng Jing, Shaoxiong Wang, and Jian Ma. 2018. “S100A8/A9 in Inflammation.” Frontiers in Immunology 9: 1298. https://doi.org/10.3389/fimmu.2018.01298

[21] Dheda, Keertan, Stephan K. Schwander, Bingdong Zhu, Richard N. Van Zyl-Smit, and Ying Zhang. 2010. “The Immunology of Tuberculosis: From Bench to Bedside.” Respirology 15: 433-450. https://doi.org/10.1111/j.1440-1843.2010.01739.x

[22] Velásquez, Lis N., Victoria M. Delpino, Andrés E. Ibañez, Lorena M. Coria, Cruz M. Miraglia, Romina Scian, Juliana Cassataro, Guillermo H. Giambartolomei, and Paula Barrionuevo. 2012. “Brucella Abortus Induces Apoptosis of Human T Lymphocytes.” Microbes and Infection 14: 639-650. https://doi.org/10.1016/j.micinf.2012.02.004

[23] Bai, Yunmeng, Meiling Hu, Zixi Chen, Jinfen Wei, and Hongli Du. 2021. “Single-Cell Transcriptome Analysis Reveals RGS1 as a New Marker and Promoting Factor for T-Cell Exhaustion in Multiple Cancers.” Frontiers in Immunology 12: 767070. https://doi.org/10.3389/fimmu.2021.767070

[24] Moncho-Amor, V., I. Ibañez de Cáceres, E. Bandres, B. Martínez-Poveda, J. L. Orgaz, I. Sánchez-Pérez, S. Zazo, et al. 2011. “DUSP1/MKP1 Promotes Angiogenesis, Invasion and Metastasis in Non-Small-Cell Lung Cancer.” Oncogene 30: 668-678. https://doi.org/10.1038/onc.2010.449

[25] Wang, Rongjing, Yuchao Zhang, Shiwei Guo, Siyu Pei, Wei Guo, Zhenchuan Wu, and Hailong Wang, et al. 2023. “Single-Cell RNA Sequencing Reveals the Suppressive Effect of PPP1R15A Inhibitor Sephin1 in Antitumor Immunity.” iScience 26: 105954. https://doi.org/10.1016/j.isci.2023.105954

[26] Preston, Gloria A., Tracy T. Lyon, Yuxin Yin, Jason E. Lang, Gregory Solomon, Lois Annab, Dayalan G. Srinivasan, David A. Alcorta, and Carl J. Barrett. 1996. “Induction of Apoptosis by C-Fos Protein.” Molecular and Cellular Biology 16: 211-218. https://doi.org/10.1128/mcb.16.1.211

[27] Zhang, Peng, Pixiao Wang, lingping Zhao, Xin Zhang, Yanxiao Ji, Xiaojing Zhang, Chun Fang, et al. 2018. “The Deubiquitinating Enzyme TNFAIP3 Mediates Inactivation of Hepatic ASK1 and Ameliorates Nonalcoholic Steatohepatitis.” Nature Medicine 24: 84-94. https://doi.org/10.1038/nm.4453

[28] Huang, Di, Xueman Chen, Xin Zeng, Liyan Lao, Jiaqian Li, Yue Xing, Yiwen Lu, et al. 2021. “Targeting Regulator of G Protein Signaling 1 in Tumor-Specific T Cells Enhances Their Trafficking to Breast Cancer.” Nature Immunology 22: 865-879. https://doi.org/10.1038/s41590-021-00939-9

[29] Sade-Feldman, Moshe, Keren Yizhak, Stacey L. Bjorgaard, John P. Ray, Carl G. de Boer, Russell W. Jenkins, David J. Lieb, et al. 2018. “Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma.” Cell 175: 998-1013.e20. https://doi.org/10.1016/j.cell.2018.10.038

[30] Veglia, Filippo, Michela Perego, and Dmitry Gabrilovich. 2018. “Myeloid-Derived Suppressor Cells Coming of Age.” Nature Immunology 19: 108-119. https://doi.org/10.1038/s41590-017-0022-x

[31] Gu, J. J., Z. Wang, R. Reeves, and N. S. Magnuson. 2009. “PIM1 Phosphorylates and Negatively Regulates ASK1-Mediated Apoptosis.” Oncogene 28: 4261-4271. https://doi.org/10.1038/onc.2009.276

[32] Mukaida, Naofumi, Ying-Ying Wang, and Ying-Yi Li. 2011. “Roles of Pim-3, a Novel Survival Kinase, in Tumorigenesis.” Cancer Science 102: 1437-1442. https://doi.org/10.1111/j.1349-7006.2011.01966.x

[33] He, Zhihong, Jie He, and Keping Xie. 2023. “KLF4 Transcription Factor in Tumorigenesis.” Cell Death Discovery 9: 118. https://doi.org/10.1038/s41420-023-01416-y

[34] Skendros, P., and P. J. Boura. 2013. “Immunity to Brucellosis.” Revue Scientifique et Technique de l'OIE 32: 137-147. https://doi.org/10.20506/rst.32.1.2190

[35] Skendros, Panagiotis, Georgios Pappas, and Panagiota Boura. 2011. “Cell−Mediated Immunity in Human Brucellosis.” Microbes and Infection 13: 134-142. https://doi.org/10.1016/j.micinf.2010.10.015

[36] Guo, Xiaoyi, Hui Zeng, Mengjuan Li, Yu Xiao, Guojing Gu, Zhenhui Song, Xuehong Shuai, et al. 2023. “The Mechanism of Chronic Intracellular Infection With Brucella Spp.” Frontiers in Cellular and Infection Microbiology 13: 1129172. https://doi.org/10.3389/fcimb.2023.1129172

[37] Merad, Miriam, and Jerome C. Martin. 2020. “Pathological Inflammation in Patients With COVID-19: A Key Role for Monocytes and Macrophages.” Nature Reviews Immunology 20: 355-362. https://doi.org/10.1038/s41577-020-0331-4

[38] Mengos, April E., Dennis A. Gastineau, and Michael P. Gustafson. 2019. “The CD14⁺HLA-DR^lo/neg Monocyte: An Immunosuppressive Phenotype That Restrains Responses to Cancer Immunotherapy.” Frontiers in Immunology 10: 1147. https://doi.org/10.3389/fimmu.2019.01147

[39] Wang, Yi, Xiaoxia Wang, Laurence Don Wai Luu, Jieqiong Li, Xiaodai Cui, Hailan Yao, Shaojin Chen, et al. 2022. “Single-Cell Transcriptomic Atlas Reveals Distinct Immunological Responses between COVID-19 Vaccine and Natural SARS-CoV-2 Infection.” Journal of Medical Virology 94: 5304-5324. https://doi.org/10.1002/jmv.28012

[40] Wang, Yi, Xiaoxia Wang, Laurence Don Wai Luu, Shaojin Chen, Fu Jin, Shufang Wang, Xiaolan Huang, et al. 2022. “Proteomic and Metabolomic Signatures Associated With the Immune Response in Healthy Individuals Immunized With an Inactivated SARS-CoV-2 Vaccine.” Frontiers in Immunology 13: 848961. https://doi.org/10.3389/fimmu.2022.848961

[41] Korsunsky, Ilya, Nghia Millard, Jean Fan, Kamil Slowikowski, Fan Zhang, Kevin Wei, Yuriy Baglaenko, et al. 2019. “Fast, Sensitive and Accurate Integration of Single-Cell Data With Harmony.” Nature Methods 16: 1289-1296. https://doi.org/10.1038/s41592-019-0619-0

[42] Traag, V. A., L. Waltman, and N. J. van Eck. 2019. “From Louvain to Leiden: Guaranteeing Well-Connected Communities.” Scientific Reports 9: 5233. https://doi.org/10.1038/s41598-019-41695-z

[43] Wang, Yi, Xiaolan Huang, Fang Li, Xinbei Jia, Nan Jia, Jin Fu, Shuang Liu, et al. 2023. “Serum-Integrated Omics Reveal the Host Response Landscape for Severe Pediatric Community-Acquired Pneumonia.” Critical Care 27: 79. https://doi.org/10.1186/s13054-023-04378-w

RIGHTS & PERMISSIONS

2024 The Author(s). iMeta published by John Wiley & Sons Australia, Ltd on behalf of iMeta Science.